MeSH term
Frequency | Condition_Probility | DNA Primers/chemistry | 2 | 0.0 |
Disease Progression | 2 | 0.0 |
Humans | 27 | 0.0 |
Male | 23 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 11 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Time Factors | 4 | 0.0 |
Adult | 3 | 0.0 |
Aged | 6 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Animals | 8 | 0.0 |
Female | 5 | 0.0 |
In Situ Hybridization | 3 | 0.0 |
Mice | 7 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Middle Aged | 7 | 0.0 |
Cell Division | 2 | 0.0 |
Mice, SCID | 3 | 0.0 |
Phenotype | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Tumor Cells, Cultured | 9 | 0.0 |
Immunohistochemistry | 5 | 0.0 |
Membrane Glycoproteins/*biosynthesis/genetics | 2 | 3.0 |
Microscopy, Confocal | 3 | 0.0 |
Neoplasm Proteins/*biosynthesis/genetics | 2 | 1.0 |
RNA, Messenger/biosynthesis/genetics | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 14 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 9 | 0.0 |
Tumor Markers, Biological/*biosynthesis/genetics | 2 | 6.0 |
Gene Expression Profiling | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Membrane Glycoproteins/*biosynthesis | 2 | 2.0 |
Neoplasm Proteins/*biosynthesis | 2 | 2.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Comparative Study | 3 | 0.0 |
Membrane Glycoproteins/biosynthesis/*genetics | 2 | 6.0 |
Neoplasm Proteins/biosynthesis/*genetics | 2 | 2.0 |
Antigens, Neoplasm/*immunology | 3 | 1.0 |
Membrane Glycoproteins/*immunology | 2 | 1.0 |
Neoplasm Proteins/*immunology | 2 | 5.0 |
Prostatic Neoplasms/*diagnosis | 2 | 4.0 |
Cancer Vaccines/immunology | 2 | 10.0 |
Gene Expression | 2 | 0.0 |
Organ Specificity | 2 | 0.0 |
T-Lymphocytes, Cytotoxic/immunology | 2 | 0.0 |
Antigens, Ly/*genetics | 2 | 20.0 |
Antigens, Neoplasm/genetics | 2 | 7.0 |
Molecular Sequence Data | 4 | 0.0 |
Tumor Markers, Biological/genetics | 2 | 2.0 |
Chromosome Mapping | 2 | 0.0 |
Bladder Neoplasms/*diagnosis | 2 | 33.0 |
Amino Acid Sequence | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Prostate/*metabolism | 2 | 2.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |